Neptune Technologies Bioresour (NASDAQ:NEPT)

CAPS Rating: 1 out of 5

The Company develops proprietary and potent health ingredients from underexploited marine biomasses, such as krill, with its patented extraction process.


Player Avatar bIlluminati (30.53) Submitted: 1/3/2013 3:36:25 PM : Underperform Start Price: $1.80 NEPT Score: +7.65

No factory, no product, few employees. Should go to zero. Acasti subsidiary (ACPHF) has a price of 2.15, book value of 0.17, traded last 10 days at 333 shares/day. APO.V, its Canadian symbol, trades more, but its book value is an issue with negative cash flow.

Featured Broker Partners